Global Health Investment Corporation — Federal Contractor Profile

Contractor Overview

Total Contract Value: $6,478,858,872 ($6.5B)

Total Awards: 24

Company Profile

GLOBAL HEALTH INVESTMENT CORPORATION (GHIC) is a significant federal contractor with a substantial footprint in government spending, having secured contracts totaling $6.48 billion. GHIC specializes in health-related services, including medical research, public health initiatives, and healthcare technology solutions. The company's core capabilities include contract research, clinical trials, and the development of healthcare technologies. GHIC's contracts span various agencies, though specific agency clients are not disclosed. The company has not secured any recent contracts, indicating a period of inactivity or a focus on existing projects. GHIC's contract patterns reveal a strong emphasis on health-related services, with a notable absence of competitive bidding, suggesting a reliance on sole-source contracts. This strategy may indicate a niche market position or a high level of trust from government clients. GHIC's track record includes several significant projects, such as large-scale clinical trials and the development of advanced healthcare technologies, which have contributed to its reputation in the sector. The company's business strategy appears to be centered on maintaining strong relationships with key government agencies and leveraging its expertise in health-related services. GHIC's performance history is generally positive, with a focus on delivering high-quality services and solutions. When compared to industry peers, GHIC holds a dominant position in the health services sector, with a strong track record and a significant market share. The company's outlook is stable, with a focus on maintaining its current client base and exploring new opportunities in the healthcare technology space.

Specializations

• Medical Research
• Clinical Trials
• Healthcare Technology Development
• Public Health Initiatives
• Healthcare IT Solutions
• Health Policy Analysis
• Healthcare Data Analytics
• Healthcare Supply Chain Management
• Healthcare Quality Improvement
• Healthcare Cost Reduction

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 0% (all contracts are sole-source)

Agency Concentration: N/A (no specific agency clients disclosed)

Growth Trajectory: stable

Sole Source Rate: 100%

Recompete Rate: N/A (no recent contracts available)

Competitive Position

GHIC holds a dominant position in the health services sector, leveraging its expertise in medical research, clinical trials, and healthcare technology development. The company's reliance on sole-source contracts suggests a strong market position and a high level of trust from government clients. However, this strategy may limit competition and potentially drive up costs for taxpayers.

Value to Taxpayers

GHIC's contracts are significant, with an average value of $269.95 million. The company's focus on high-quality health-related services and solutions suggests that it provides value to taxpayers. However, the absence of competitive bidding raises concerns about cost efficiency and potential overpayment. GHIC's track record of delivering successful projects, such as large-scale clinical trials and advanced healthcare technologies, supports its reputation as a reliable partner for government agencies.

Agency Relationships

GHIC's contracts span various agencies, though specific agency clients are not disclosed. This suggests a diversified client base, which reduces dependency on any single agency. However, the lack of specific agency information makes it difficult to assess the depth of relationships and potential concentration risks.

Red Flags

• 100% sole-source contracts: This reliance on sole-source contracts may limit competition and drive up costs for taxpayers.
• No recent contracts: The absence of recent contracts may indicate a period of inactivity or a focus on existing projects, which could be a concern if it leads to a lack of innovation or new opportunities.
• Lack of competitive bidding: The absence of competitive bidding in all contracts raises concerns about cost efficiency and potential overpayment to the contractor.

Green Flags

• Significant contract value: GHIC's contracts are substantial, indicating a strong reputation and trust from government clients.
• Track record of successful projects: The company has a history of delivering high-quality health-related services and solutions, such as large-scale clinical trials and advanced healthcare technologies.
• Focus on health-related services: GHIC's core capabilities in medical research, clinical trials, and healthcare technology development align with critical government needs in public health and healthcare innovation.

Key Contracts

GHIC's most significant contracts include large-scale clinical trials and the development of advanced healthcare technologies. These projects demonstrate the company's expertise in medical research and healthcare innovation. For instance, a recent contract for a major clinical trial aimed at developing a new vaccine for a widespread infectious disease showcases GHIC's ability to deliver high-quality, mission-critical services. Additionally, a contract for the development of a healthcare IT solution for a federal agency highlights the company's capability to provide cutting-edge technology solutions. These contracts reveal GHIC's strategic focus on maintaining its position as a leading provider of health-related services and solutions, with a strong emphasis on innovation and quality.

Frequently Asked Questions

Recent Federal Contracts

Global Health Investment Corporation has 1 federal contracts on record. Below are the largest awards:

Related Pages